Hospital exposure as a risk factor for the transmission of measles: A case-control study in Turkey.
Abstract
Objective: During a nationwide measles epidemic in 2013, we conducted an investigation in Sanliurfa province to assess risk factors for measles infections. Methods: In a case-control design, we compared the history of hospital exposures for 189 randomly selected laboratory-confirmed patients (aged <15 years) residing in the central district and control-individuals matched for neighbourhood and age. We estimated the effectiveness of the vaccine (VE). Results:For infants from 0-11 months, 53.8% of the case and 23.8% of the controls had visited a hospital during one the month prior to the onset of the case’s rash (ORadj=3.7, 95% CI=1.6–8.6). For children from 1–6 years, 48.2% of the cases and 14.3% of the controls visited a hospital during one month prior to the onset case’s rash (ORadj=5.5,95% CI=2.5–12.8) and 59.7% of cases had not completed one dose of measles vaccine by 12 months, compared with
14.7% of controls (ORadj=7.4,95% CI=2.1–26.9; VE=86%,95% CI=52-96%). For children from 7– 14 years, 53.8% of the cases had not completed one dose of measles vaccination by age 12 months, compared with 15.4% of controls (ORadj=6.7,95% CI=1.7–26.6; VE=85%, 95% CI=41-96%). Conclusion: We conclude that the hospitals facilitated measles transmission during this epidemic. We recommend triage febrile patients and patients with a rash in healthcare settings, and strengthening measles vaccination programme..
Keywords: Measles; Measles Vaccine; Nosocomial Infections; Risk Factors; Case Control Study
Keywords
Measles,Measles vaccine,Nosocomial infections,Case-control studies
References
- 1. Measles. World Health Organization website. Available at: http://www.who.int/immunization/topics/ measles/en/index.html. Accessed February 18, 2014.
- 2. Global eradication of measles. Report by the Secretariat. World Health Organization website. Available at: http://apps.who.int/gb/ebwha/pdf_files/w ha63/a63_18-en.pdf. Accessed February 26, 2014.
- 3. Eliminating measles and rubella: framework for the verification process in the WHO European Region. World Health Organization, Regional Office for Europe website. Available at: http://www.euro.who.int/en/healthtopics/communicable-diseases/measlesandrubella/publications/2012/eliminatingmeasles-and-rubella-framework-for-theverification-process-in-the-who-europeanregion. Accessed February 18, 2014.
- 4. Circular on measles, rubella and congenital rubella surveillance 2010. Public Health Institute of Turkey, Ministry of Health of Turkey website. Available at: http://www.saglik.gov.tr/TR/belge/1- 10232/kizamik-kizamikcik-ve-konjenitalkizamikcik-kks-surveya-.htlm. Accessed February 18, 2014.
- 5. Republic of Turkey Ministry of Health. Health Statistics Yearbook, 2008. Ministry of Health of Turkey website. Accessed February 18, 2014.
- 6. General Directorate of Primary Health Care Services: 2001 Statistical Yearbook. Ministry of Health of Turkey website. Available at: http://www.saglik.gov.tr/TR/belge/1- 3020/eski2yeni.html. Accessed February 18, 2014.
- 7. Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. European Centre for Disease Prevention and Control, Stockholm: ECDC website. Available at: http://ecdc.europa.eu/en/publications/Pub lications/Annual-Epidemiological-Report- 2012.pdf. Accessed February 24, 2014.
- 8. Measles Report. Turkish Society of Public Health Specialist (Halk Sağlığı Uzmanları Derneği). (Kızamık Raporu Mart, 2013) (Turkish). Available at: http://xa.yimg.com/kq/groups/13740820/ 620990780/name/HASUDER_KIZAMIK_RA PORU.pdf. Accessed November 12, 2015.
- 9. Public Health Instution of Turkey. National Measles Surveillance. Unpublished data. Accessed April 14, 2013. 10. Orenstein WA, Bernier RH, Dondero TJ, Hinman AR, Marks JS, Bart KJ, et al. Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63(6):1055–1068.
- 11. Weinberg GA, Szilagyi PG. Vaccine Epidemiology: Efficacy, Effectiveness, and he Translational Research Roadmap. J Infect Dis 2010;201(11):1607–1610.